UPDATE: HTG, John Wayne Cancer Institute Partner on Melanoma Assays | GenomeWeb

This article has been updated with comments from HTG's CEO and additional background information.

NEW YORK (GenomeWeb News) – HTG Molecular Diagnostics today said that it has partnered with the John Wayne Cancer Institute to commercialize melanoma assays based on molecular signatures identified through a research collaboration between the partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.